BWS
PCVX icon

Buck Wealth Strategies’s Vaxcyte PCVX Stock Holding History

Buck Wealth Strategies’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116 Buy
+2
New +$109 ﹤0.01% 1132

Other funds holding PCVX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Buck Wealth Strategies's PCVX Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Vaxcyte (PCVX) in Q2 2026: 2 shares worth $116. The stake represents ﹤0.01% of the portfolio and ranks #1132 among its holdings.

124 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Buck Wealth Strategies held 2 shares of Vaxcyte worth $116 as of Q2 2026.
  • Vaxcyte was a new Buck Wealth Strategies position in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1132 holding.
  • 124 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.